1Ward MR, Agrotis A, Kanellakis P, et al. Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting. Aterioscler Thromb Vasc Biol.2002.22:940 - 948.
2Zohlnhofer D, Richter T, Neumann F, et al. Transcriptome analysis reveals a role of interferon-gamma in human neointima formation.Mol Cell,2001,7:1059 - 1069.
3Sarkar R, Meinberg EG, Stanley JC, et al. Nitric oxide reversibly inhibits the migration of P53 cultured vascular smooth muscle cells.Circ Res, 1996,78:225 - 23.
4Christen T, Verin V, Bochaton -Piallat M, et al. Mechanisms of neointima formation and remodeling in the porcine coronary artery.Circulation,2001,103:882 - 888.
5Paiement P, Bertrand O, Scortichini D, et al. Local Delivery of TGF-b Antibodies to Prevent Neointima Formation after Balloon Injury in a Pig Coronary Artery Model. J Invasive Cardiol, 1998,10:470 - 476.
6George SJ, Johnson JL, Angelini GD, et al. Adenovirus - mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum Gene Ther, 1998,9 : 867 - 877.
7Hojo Y, Ikeda U, Katsuki T, et al. Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty.Athemsclemsis,2002,161 : 185 - 192.
8Fitzgerald M, Hayward IP, Thomas AC, et al. Matrix metalloproteinase can facilitate the heparanase - induced promotion of phenotype change in vascular smooth muscle cells. Atherosclerosis, 1999,145 :97 - 106.
9Ulloa L,Doody J,Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon - gamma/STAT pathway. Nature, 1999,397:710 - 713.
同被引文献10
1Bauters C, Isner JM. The biology of restenosis. Prog Cardiovasc Dis, 1997,40 : 107-116.
2Curcio A,Torella D, Indolfi C. Mechanisms of smooth muscle cell prolif- eration and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J,2011,75 : 1287-1296.
3Rakesh K,Agrawal DK. Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells. Int Immunopharma- col ,2005,5 : 1487-1506.
4Perez J, Torres RA, Rocic P, et al. PYK2 signaling is required for PDGF- dependent vascular smooth muscle cell proliferation. Am J Physiol Cell Physio1,2011,301 : C242-251.
5Madjd Z, Mehrjerdi AZ, Sharifi AM, et al. CD44 + cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours. Cancer Immun ,2009,9:4.
6Sonderegger S, Haslinger P, Sabri A, et al. Wingless (Wnt) -3 A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation. Endocri- nology,2010,151:211-220.
7Liu P, Yang J, Pei J, et al. Regulation of MT1-MMP activity by beta-cate- nin in MDCK non-cancer and I-IT1080 cancer cells. J Cell Physiol,2010, 225:810-821.
